Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $18.1100 (-8.72%) ($17.3100 - $18.9500) on Sat. Jan. 28, 2006. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.52% (three month average) | RSI | 55 | Latest Price | $18.1100(-8.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.9% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting BCRX price | BCRX will decline at least -3.26% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.26% (StdDev 6.52%) | Hourly BBV | 0 () | Intraday Trend | -2% | | | |
|
Resistance Level | $19.26 | 5 Day Moving Average | $19.65(-7.84%) | 10 Day Moving Average | $20.16(-10.17%) | 20 Day Moving Average | $19.26(-5.97%) | To recent high | -19.2% | To recent low | 61% | Market Cap | $N/A | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |